[1]
Abdul Samad, Z. and Jameel, A. 2025. FDA Approves Axatilimab: A New Standard in Chronic Graft-Versus-Host Disease Therapy . Journal of the Pakistan Medical Association. 75, 12 (Nov. 2025), 2010–2011. DOI:https://doi.org/10.47391/JPMA.25-22322.